Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 9158562, 9 pages
http://dx.doi.org/10.1155/2016/9158562
Research Article

Islet Brain 1 Protects Insulin Producing Cells against Lipotoxicity

1Service of Internal Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, 1011 Lausanne, Switzerland
2University of Lille, European Genomic Institute for Diabetes (EGID) FR 3508, UMR CNRS 8199, Faculty of Medicine West, 1 place de Verdun, 59045 Lille, France
3Department of Pharmacology and the Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada
4University of Lille, EGID FR 3508, Department of Endocrine Surgery, Lille University Hospital, UMR INSERM 1190, Lille, France
5Department of Molecular and Cellular Biochemistry, Ohio State University, 1060 Carmack Road, Columbus, OH, USA

Received 6 January 2015; Accepted 6 March 2015

Academic Editor: Li Chen

Copyright © 2016 Saška Brajkovic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Bonnefond, P. Froguel, and M. Vaxillaire, “The emerging genetics of type 2 diabetes,” Trends in Molecular Medicine, vol. 16, no. 9, pp. 407–416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. X. Lin, K. Song, N. Lim et al., “Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score—the CoLaus Study,” Diabetologia, vol. 52, no. 4, pp. 600–608, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Cnop, L. Ladrière, M. Igoillo-Esteve, R. F. Moura, and D. A. Cunha, “Causes and cures for endoplasmic reticulum stress in lipotoxic β-cell dysfunction,” Diabetes, Obesity and Metabolism, vol. 12, supplement 2, pp. 76–82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. J. Meier, T. G. K. Breuer, R. C. Bonadonna et al., “Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans,” Diabetologia, vol. 55, no. 5, pp. 1346–1354, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza, and P. C. Butler, “β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes,” Diabetes, vol. 52, no. 1, pp. 102–110, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Y. Donath, D. M. Schumann, M. Faulenbach, H. Ellingsgaard, A. Perren, and J. A. Ehses, “Islet inflammation in type 2 diabetes: from metabolic stress to therapy,” Diabetes Care, vol. 31, supplement 2, pp. S161–S164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Eguchi, I. Manabe, Y. Oishi-Tanaka et al., “Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation,” Cell Metabolism, vol. 15, no. 4, pp. 518–533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. B. Hoppa, S. Collins, R. Ramracheya et al., “Chronic palmitate exposure inhibits insulin secretion by dissociation of Ca2+ channels from secretory granules,” Cell Metabolism, vol. 10, no. 6, pp. 455–465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Poitout, “Glucolipotoxicity of the pancreatic β-cell: Myth or reality?” Biochemical Society Transactions, vol. 36, no. 5, pp. 901–904, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Maedler, G. A. Spinas, D. Dyntar, W. Moritz, N. Kaiser, and M. Y. Donath, “Distinct effects of saturated and monounsaturated fatty acids on β-cell turnover and function,” Diabetes, vol. 50, no. 1, pp. 69–76, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Plaisance, V. Perret, D. Favre et al., “Role of the transcriptional factor C/EBPbeta in free fatty acid-elicited beta-cell failure,” Molecular and Cellular Endocrinology, vol. 305, no. 1-2, pp. 47–55, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Kashyap, R. Belfort, A. Gastaldelli et al., “A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes,” Diabetes, vol. 52, no. 10, pp. 2461–2474, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. M. L. Watson, K. Macrae, A. E. Marley, and H. S. Hundal, “Chronic effects of palmitate overload on nutrient-induced insulin secretion and autocrine signalling in pancreatic MIN6 beta cells,” PLoS ONE, vol. 6, no. 10, Article ID e25975, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. D. K. Hagman, M. G. Latour, S. K. Chakrabarti et al., “Cyclical and alternating infusions of glucose and intralipid in rats inhibit insulin gene expression and Pdx-1 binding in islets,” Diabetes, vol. 57, no. 2, pp. 424–431, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. C. Åkerfeldt, J. Howes, J. Y. Chan et al., “Cytokine-Induced β-cell death is independent of endoplasmic reticulum stress signaling,” Diabetes, vol. 57, no. 11, pp. 3034–3044, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Kharroubi, L. Ladrière, A. K. Cardozo, Z. Dogusan, M. Cnop, and D. L. Eizirik, “Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress,” Endocrinology, vol. 145, no. 11, pp. 5087–5096, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. D. R. Laybutt, A. M. Preston, M. C. Akerfeldt et al., “Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes,” Diabetologia, vol. 50, no. 4, pp. 752–763, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S.-M. Lee, S.-E. Choi, J.-H. Lee et al., “Involvement of the TLR4 (Toll-like receptor4) signaling pathway in palmitate-induced INS-1 beta cell death,” Molecular and Cellular Biochemistry, vol. 354, no. 1-2, pp. 207–217, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. A. Cunha, P. Hekerman, L. Ladrière et al., “Initiation and execution of lipotoxic ER stress in pancreatic β-cells,” Journal of Cell Science, vol. 121, no. 14, pp. 2308–2318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Tanabe, Y. Liu, S. D. Hasan et al., “Glucose and fatty acids synergize to promote B-cell apoptosis through activation of glycogen synthase kinase 3β independent of JNK activation,” PLoS ONE, vol. 6, no. 4, Article ID e18146, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Bonny, P. Nicod, and G. Waeber, “IB1, a JIP-1-related nuclear protein present in insulin-secreting cells,” Journal of Biological Chemistry, vol. 273, no. 4, pp. 1843–1846, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Bonny, A. Oberson, M. Steinmann, D. F. Schorderet, P. Nicod, and G. Waeber, “IB1 reduces cytokine-induced apoptosis of insulin-secreting cells,” The Journal of Biological Chemistry, vol. 275, no. 22, pp. 16466–16472, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Waeber, J. Delplanque, C. Bonny et al., “The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes,” Nature Genetics, vol. 24, no. 3, pp. 291–295, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Abderrahmani, M. Steinmann, V. Plaisance et al., “The transcriptional repressor REST determines the cell-specific expression of the human MAPK8IP1 gene encoding IB1 (JIP-1),” Molecular and Cellular Biology, vol. 21, no. 21, pp. 7256–7267, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Ling, M. Van de Casteele, J. Dong et al., “Variations in IB1/JIP1 expression regulate susceptibility of beta-cells to cytokine-induced apoptosis irrespective of c-Jun NH2-terminal kinase signaling,” Diabetes, vol. 52, no. 10, pp. 2497–2502, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Ferdaoussi, S. Abdelli, J.-Y. Yang et al., “Exendin-4 protects β-cells from interleukin-1β-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway,” Diabetes, vol. 57, no. 5, pp. 1205–1215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J.-A. Haefliger, T. Tawadros, L. Meylan et al., “The scaffold protein IB1/JIP-1 is a critical mediator of cytokine-induced apoptosis in pancreatic β cells,” Journal of Cell Science, vol. 116, no. 8, pp. 1463–1469, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Favre, G. Niederhauser, D. Fahmi et al., “Role for inducible cAMP early repressor in promoting pancreatic beta cell dysfunction evoked by oxidative stress in human and rat islets,” Diabetologia, vol. 54, no. 9, pp. 2337–2346, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Abderrahmani, G. Niederhauser, D. Favre et al., “Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells,” Diabetologia, vol. 50, no. 6, pp. 1304–1314, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Beeler, B. M. Riederer, G. Waeber, and A. Abderrahmani, “Role of the JNK-interacting protein 1/islet brain 1 in cell degeneration in Alzheimer disease and diabetes,” Brain Research Bulletin, vol. 80, no. 4-5, pp. 274–281, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Dickens, J. S. Rogers, J. Cavanagh et al., “A cytoplasmic inhibitor of the JNK signal transduction pathway,” Science, vol. 277, no. 5326, pp. 693–696, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. A. K. Busch, D. Cordery, G. S. Denyer, and T. J. Biden, “Expression profiling of palmitate- and oleate-regulated genes provides novel insights into the effects of chronic lipid exposure on pancreatic β-cell function,” Diabetes, vol. 51, no. 4, pp. 977–987, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Lilla, G. Webb, K. Rickenbach et al., “Differential gene expression in well-regulated and dysregulated pancreatic beta-cell (MIN6) sublines,” Endocrinology, vol. 144, no. 4, pp. 1368–1379, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Favre, E. Le Gouill, D. Fahmi et al., “Impaired expression of the inducible cAMP early repressor accounts for sustained adipose CREB activity in obesity,” Diabetes, vol. 60, no. 12, pp. 3169–3174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Hai, C. D. Wolfgang, D. K. Marsee, A. E. Allen, and U. Sivaprasad, “ATF3 and stress responses,” Gene Expression, vol. 7, no. 4-6, pp. 321–335, 1999. View at Google Scholar · View at Scopus
  36. Y.-P. Zhou, K. Marlen, J. F. Palma et al., “Overexpression of repressive cAMP response element modulators in high glucose and fatty acid-treated rat islets: a common mechanism for glucose toxicity and lipotoxicity?” The Journal of Biological Chemistry, vol. 278, no. 51, pp. 51316–51323, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Abderrahmani, S. Cheviet, M. Ferdaoussi, T. Coppola, G. Waeber, and R. Regazzi, “ICER induced by hyperglycemia represses the expression of genes essential for insulin exocytosis,” EMBO Journal, vol. 25, no. 5, pp. 977–986, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. E. J. Zmuda, L. Qi, M. X. Zhu, R. G. Mirmira, M. R. Montminy, and T. Hai, “The roles of ATF3, an adaptive-response gene, in high-fat-diet-induced diabetes and pancreatic beta-cell dysfunction,” Molecular Endocrinology, vol. 24, no. 7, pp. 1423–1433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. M. G. Hartman, D. Lu, M.-L. Kim et al., “Role for activating transcription factor 3 in stress-induced β-cell apoptosis,” Molecular and Cellular Biology, vol. 24, no. 13, pp. 5721–5732, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Sargsyan and P. Bergsten, “Lipotoxicity is glucose-dependent in INS-1E cells but not in human islets and MIN6 cells,” Lipids in Health and Disease, vol. 10, article 115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. T. J. Biden, E. Boslem, K. Y. Chu, and N. Sue, “Lipotoxic endoplasmic reticulum stress, beta cell failure, and type 2 diabetes mellitus,” Trends in Endocrinology and Metabolism, vol. 25, no. 8, pp. 389–398, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Zhang, H. Hoff, and C. Sell, “Downregulation of IRS-1 protein in thapsigargin-treated human prostate epithelial cells,” Experimental Cell Research, vol. 289, no. 2, pp. 352–358, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. O. Kristensen, S. Guenat, I. Dar et al., “A unique set of SH3-SH3 interactions controls IB1 homodimerization,” EMBO Journal, vol. 25, no. 4, pp. 785–797, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Allaman-Pillet, J. Størling, A. Oberson et al., “Calcium- and proteasome-dependent degradation of the JNK scaffold protein islet-brain 1,” Journal of Biological Chemistry, vol. 278, no. 49, pp. 48720–48726, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Zhang, J. Liu, G. MacGibbon, M. Dragunow, and G. J. S. Cooper, “Increased expression and activation of c-Jun contributes to human amylin-induced apoptosis in pancreatic islet β-cells,” Journal of Molecular Biology, vol. 324, no. 2, pp. 271–285, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. C. R. Weston and R. J. Davis, “The JNK signal transduction pathway,” Current Opinion in Cell Biology, vol. 19, no. 2, pp. 142–149, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. E. T. Coffey, “Nuclear and cytosolic JNK signalling in neurons,” Nature Reviews Neuroscience, vol. 15, no. 5, pp. 285–299, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Abdelli, J. Puyal, C. Bielmann et al., “JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis,” Diabetologia, vol. 52, no. 9, pp. 1871–1880, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Ezanno, V. Pawlowski, S. Abdelli et al., “JNK3 is required for the cytoprotective effect of exendin 4,” Journal of Diabetes Research, vol. 2014, Article ID 814854, 5 pages, 2014. View at Publisher · View at Google Scholar
  50. M. Prause, D. P. Christensen, N. Billestrup, and T. Mandrup-Poulsen, “JNK1 protects against glucolipotoxicity-mediated beta-cell apoptosis,” PLoS ONE, vol. 9, no. 1, Article ID e87067, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. M. A. Bogoyevitch, K. R. W. Ngoei, T. T. Zhao, Y. Y. C. Yeap, and D. C. H. Ng, “c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges,” Biochimica et Biophysica Acta—Proteins and Proteomics, vol. 1804, no. 3, pp. 463–475, 2010. View at Publisher · View at Google Scholar · View at Scopus